我是 LongbridgeAI，我可以總結文章信息。
- Curaleaf 對極光大麻拒絕其提高後的收購要約提出質疑，並對董事會於 2026 年 10 月 14 日提出的建議表示異議。 * 據收購方稱，每股 5 美元的報價較極光大麻未受影響的 30 日成交量加權平均股價溢價 86%。 * 根據該質疑聲明，極光大麻在向其他潛在買家提供機密信息的同時，卻拒絕收購方進行盡職調查訪問。 * 收購方表示已準備好開展盡職調查，並認為通過談判可以解決極光大麻對要約條件和協同效應估算的擔憂。 Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE75049) on October 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)
